Organoids can potentially eliminate animal testing, accelerate medical research and trials, and improve our understanding of diseases, ultimately leading to the discovery of new treatments. They can be used to study organ development, function, diseases, and the effects of various stimuli and treatments—something that feels like it’s straight out of science fiction.

Dispersible Emergency Response Treatment (DERT) represents a significant leap forward in hemostatic care. Engineered for the needs of military personnel and first responders, DERT dramatically accelerates blood clotting and reduces blood loss from traumatic injuries to induce near-instantaneous clotting.